Clinical trial
Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT
NCT00084838 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00084838 |
|---|---|
| Title | Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT |
| Official title | A Phase II Study of Intrathecal and Systemic Chemotherapy With Radiation Therapy for Children With Central Nervous System Atypical Teratoid/Rhabdoid Tumor (AT/RT) Tumor |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Central Nervous System Tumor, Pediatric |
| Intervention type | Biological, Drug, Radiation |
| Interventions | filgrastim, cisplatin, cyclophosphamide, cytarabine, dexrazoxane hydrochloride, doxorubicin hydrochloride, etoposide, leucovorin calcium, methotrexate, temozolomide and 4 more |
| Enrollment | 25 |
| Start date | Feb 1, 2003 |
| Primary completion | Feb 1, 2008 |
| Completion | Mar 1, 2013 |
| First posted | Jun 11, 2004 |
| Last update posted | Dec 24, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: